POLARx Post Approval Study (POLARx PAS)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT06170606

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06170606
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06170606. Allocation not applicable; no masking; primary purpose treatment. Start 2024-06-28 (actual); primary completion 2026-05-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
POLARx Post Approval Study (POLARx PAS)
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
Boston Scientific Cardiac Cryoablation System
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct06170606
Content hash
4aa03bfdf7c347c4c316e14759cd14514609c7137b519abe372f2209f69a1b6c